Skip to Content

Lonza Group Ltd LZAGF

Morningstar Rating
$512.00 −15.00 (2.85%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LZAGF is trading at a 14% discount.
Price
$511.08
Fair Value
$213.93
Uncertainty
High
1-Star Price
$369.98
5-Star Price
$482.70
Economic Moat
Crclrj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LZAGF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$527.00
Day Range
$512.00517.00
52-Week Range
$336.03673.62
Bid/Ask
$503.45 / $532.64
Market Cap
$38.03 Bil
Volume/Avg
388 / 1,884

Key Statistics

Price/Earnings (Normalized)
34.47
Price/Sales
5.79
Dividend Yield (Trailing)
0.77%
Dividend Yield (Forward)
0.89%
Total Yield
1.65%

Company Profile

Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Large Growth
Total Number of Employees
17,896

Competitors

Valuation

Metric
LZAGF
CTLT
02269
Price/Earnings (Normalized)
34.4799.9711.63
Price/Book Value
3.412.791.74
Price/Sales
5.792.523.67
Price/Cash Flow
23.1255.279.13
Price/Earnings
LZAGF
CTLT
02269

Financial Strength

Metric
LZAGF
CTLT
02269
Quick Ratio
1.361.541.79
Current Ratio
2.072.482.20
Interest Coverage
18.29−5.2340.97
Quick Ratio
LZAGF
CTLT
02269

Profitability

Metric
LZAGF
CTLT
02269
Return on Assets (Normalized)
5.83%−2.51%9.91%
Return on Equity (Normalized)
9.76%−6.08%14.09%
Return on Invested Capital (Normalized)
8.06%−0.60%11.82%
Return on Assets
LZAGF
CTLT
02269
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncQfjg$211.8 Bil
DHR
Danaher CorpWkkwfc$183.2 Bil
IDXX
IDEXX Laboratories IncLfhjqt$45.8 Bil
IQV
IQVIA Holdings IncFfrkh$42.6 Bil
A
Agilent Technologies IncLngvl$39.3 Bil
MTD
Mettler-Toledo International IncZrgnq$25.4 Bil
ICLR
Icon PLCFcsnzm$23.3 Bil
ILMN
Illumina IncQwmpgs$22.3 Bil
WAT
Waters CorpBvpxv$19.2 Bil
LH
Laboratory Corp of America HoldingsDtlkjkg$18.1 Bil

Sponsor Center